Pigment Cell & Melanoma Research

Papers
(The median citation count of Pigment Cell & Melanoma Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Issue Information112
34
27
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy22
Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA ‐sequencing22
TRIM 63 Promotes the Malignant Behaviors of Melanoma Cells Through Ubiquitination of P 2 RY20
SASH1 Mutations and Hereditary Disorders of Pigmentation: Review of Literature18
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma18
Cytoglobin functions as a redox regulator of melanogenesis in normal epidermal melanocytes17
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)17
Issue Information15
Oral Melanoma in Older Adults: Epidemiology, Molecular Landscape, and Treatment Strategies15
25th International Pigment Cell Conference, Bilbao, Spain IPCC 202315
Fusion Gene Detection in Driver Mutation‐Negative Melanomas Using RNA ‐Based Anchored Multiplex Polymerase Chain Reaction15
Progress in melanoma treatment: Patient's perspectives15
Microfluidic Characterization and Analysis of Circulating Tumor Cells From Patients With Metastatic Melanoma13
Issue Information13
Issue Information13
The Melanocyte and Nerve Fiber Cross‐Talk, Facilitated Also by Semaphorin‐4A, Enhances UV‐B‐Induced Melanogenesis13
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma12
Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS‐derived melanocytes11
Issue Information11
11
Issue Information11
First Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon11
PASPCR 2024 Annual Meeting, New York, NY11
Single‐cell profiling of MC1R‐inhibited melanocytes11
Celebrating the life of James J. Nordlund, MD, a larger‐than‐life scholar, mentor, and friend11
Sex Differences in Acral Lentiginous Melanoma: A Retrospective Cohort Analysis of 3617 Cases From the Surveillance, Epidemiology, and End Results Database10
Cover Image10
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma10
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models10
Mouse Tail‐Skin Dissociation and Preparation of Live Single‐Cell Suspension for Downstream Analysis of Melanocytes9
BORIS / CTCFL ‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melano9
Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population9
Rapid Diagnosis and Subtyping of Hermansky‐Pudlak Syndrome With Flow Cytometry Analysis9
Cover Image8
Issue Information8
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 20238
8
Rare Melanomas: An Area of Urgent Research and Clinical Need7
Topical antibiotics limit depigmentation in a mouse model of vitiligo7
Dominant Negative Mitf Allele Impacts Melanophore and Xanthophore Development and Reveals Collaborative Interactions With Tfec in Zebrafish Chromatophore Lineages7
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo7
Three‐dimensional imaging for the analysis of human epidermal melanocytes7
The metabolism of melanin synthesis—From melanocytes to melanoma7
SASH1 Modulates Melanin Synthesis and Melanoma Cell Metastasis via Suppression of the TGF ‐β Signaling Pathway7
7
The Proposed Categorization of Vitiligo Lesions on the Hands7
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation7
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment7
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐17
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism6
UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production6
2‐Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity6
The OSUMMER lines: A series of ultraviolet‐accelerated NRAS‐mutant mouse melanoma cell lines syngeneic to C57BL/66
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab6
Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients with Uveal Melanoma6
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model6
Pigmentation and Retinal Pigment Epithelium Thickness: A Study of the Phenotypic and Genotypic Relationships Between Ocular and Extraocular Pigmented Tissues6
ToFSIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma6
6
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants6
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance6
Patient Education in the Eye of the Beholder: Assessing the Effect of Skin Color Representation in Melanoma Educational Materials6
Prognostic and Predictive Value of ctDNA for Metastatic Uveal Melanoma: A Systematic Review and Meta‐Analysis6
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines6
Issue Information6
TFE3 promotes ferroptosis in melanoma5
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era5
Chicken Shank Color Determined by Inhibition of Dermal Melanin ( ID ) is Mediated by a Structural 5
5
Chemiexcitation in Ex Vivo Porcine Skin Model5
5
Cutaneous Pigment Cell Distributions and Skin Structure of Xenopus5
Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas5
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis5
Primary cutaneous melanoma in Black patients: An analysis of 2464 cases from the National Cancer Database 2004–20185
Advancements in melanoma cancer metastasis models5
Extreme Tumor Mutational Burden Predicts Near‐Curative Outcomes With Checkpoint Immunotherapy in Melanoma: Half the Eligible, Half the Cure5
Comparison of Disease Progression Between Amelanotic Melanoma and Melanotic Melanoma5
Segregation Between an Ornamental and a Disease Driver Gene Provides Insights Into Pigment Cell Regulation5
Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment5
Interplay of Light, Melatonin, and Circadian Genes in Skin Pigmentation Regulation5
Excimer 308‐Nm Light in the Combination Treatment of Vitiligo: A Systematic Review and Network Meta‐Analysis5
Myron Gordon Award Lecture 2023: Painting the neural crest: How studying pigment cells illuminates neural crest cell biology5
Issue Information4
New Dermoscopy Pattern in Nevus‐Associated Melanomas4
Optimisation of skin phototype classification4
Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma4
Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy4
Association of Pretreatment Tumour Microenvironment and Treatment Outcome in Patients With Locally Advanced Melanoma Treated With Isolated Limb Perfusion4
Xenopus as a model system for studying pigmentation and pigmentary disorders4
An in vitro nevus explant model for studying the effects of ultraviolet radiation4
4
An Integrated Investigation of SOX10 in Feather Color in Domestic Rock Pigeon ( Columba livia 4
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State4
RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response4
YAP Upregulation Contributes to Acquired Resistance to BET Inhibitors in Uveal Melanoma4
Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation3
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study3
LRP2 Expression in Melanoma Is Associated With a Transitory Cell State, Increased T Cell Infiltration, and Is Upregulated by IFNy Signaling3
Trained immunity in the pathogenesis of vitiligo3
Low‐Dose Baricitinib Plus Narrow‐Band Ultraviolet B for the Treatment of Progressive Non‐Segmental Vitiligo: A Prospective, Controlled, Open‐Label Study3
Identification and functional assays of single‐nucleotide variants of opsins genes in melanocytic tumors3
The classification of melanocytic gene signatures3
Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)3
Piceatannol—Can It Be Used to Treat Hyperpigmentation of the Skin?3
Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma3
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage3
X and Y Differences in Melanoma Survival Between the Sexes3
Issue Information3
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care3
Cover Image3
A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment3
3
In Memoriam: Soldano Ferrone MD, PhD (1940–2023)3
Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations3
The Role of Two Tyrosinase‐Like Glycoenzymes in Defining the Final Hue of Parrot Plumage3
Conjunctival Melanoma: A Narrative Review of Current Knowledge3
The Neuro‐Endocrinal Regulation in Vitiligo3
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants2
Development of Poliosis in Patients Treated With Immunotherapy for Metastatic Cutaneous and Non‐Cutaneous Melanoma2
Melanoma and Matrimony: Retrospective Study of Demographics, Marital Status, and Clinical Features of Patients With Acral Melanoma at a Single Academic Center2
Diacylglycerol Kinase Eta as a Novel Target in NRAS Mutant Melanoma2
Genotypic spectrum of albinism in Mali2
List of reviewers for PCMR (01.01.2023–30.09.2023)2
List of Reviewers for PCMR2
Impact of Drug–Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real‐World Study2
The Incorporation of Melanosomes by Senescent Keratinocytes Causes the Accumulation of Melanin due to Decreased Energy Metabolism2
The Yucatan miniature swine as a model for post‐inflammatory hyperpigmentation2
AP‐3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio)2
B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas2
A New Era in Leptomeningeal Disease ( LMD ): Recent Advancements in Immunocellular and Radiation Therapies in Melanoma LMD2
2
Cover Image2
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis2
The 21st International Congress of the Society for Melanoma Research2
Cholinergic Signaling Mediated by Muscarinic Receptors Triggers the Ultraviolet‐Induced Release of Melanosome in Cultured Melanoma Cells2
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities2
Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series2
Rare Germline Variants in CDKN2A ‐Negative Children and Adolescents With Cutaneous Melanoma2
2
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort2
Development and Validation of Vitiligo‐Specific‐Belief About Therapy Questionnaire (BTQ‐Vitiligo)2
Unusual Autosomal Dominant Inheritance of Oculocutaneous Albinism Type 4 (OCA‐4): Clinical and Functional Features From A Chinese Family1
Uric acid is a major chemical constituent for the whitish coloration in the medaka leucophores1
Neurological Mechanisms Exploration and Therapeutic Targets in Segmental Vitiligo Accompanied by White Hair1
Issue Information1
Epilogue1
Issue Information1
Issue Information1
Molecular skin fluorescence imaging: A tool for evaluating early melanoma development1
Twenty years of research in melanoma therapy–From “nothing works” to cures: A personal account1
1
MITF E318K: A rare homozygous case with multiple primary melanoma1
The MITF regulatory network in melanoma1
Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children1
Cancer‐Associated Fibroblast Signature Can Predict Prognosis and Therapeutic Responses in Skin Cutaneous Melanoma1
Meeting Abstracts of the ESPCR 2025 (European Society for Pigment Cell Research)1
Defining Important Aspects of Repigmentation in Vitiligo: Insights From Patients' Perspectives1
PRMT6 Inhibits Malignant Progression of Melanoma by Antagonizing Trimethylation of Histone H3K4 to Downregulate ALDH1A1 Levels1
Synonymous but Significant: New Findings of Pathological Variants in Hermansky–Pudlak Syndrome1
Identification and characterization of the compound heterozygous variants of TYR gene in a northern Chinese family with Oculocutaneous albinism type 11
20th Anniversary of the Society for Melanoma Research: Celebrating two decades of progress in melanoma research1
Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation‐Wide Study by the Italian Melanoma Intergroup ( IMI1
The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma1
QUILPEN Provides Independent and Label‐Free Single‐Cell Quantification of Pigmentation Dynamics and Organelle Content1
Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage1
A twenty year perspective on melanoma therapy1
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti‐CTLA‐4 treatment1
The Roles of PTEN in Melanoma Suppression1
Issue Information1
1
0.066164970397949